Evidence map›Paper›PMID 25426561›Full record

ArticleOncotarget2015

New mechanistic insights of integrin β1 in breast cancer bone colonization.

Laure Thibaudeau, Anna V Taubenberger, Christina Theodoropoulos, Boris M Holzapfel, Olivier Ramuz, Melanie Straub, Dietmar W Hutmacher

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Laure ThibaudeauInstitute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
Anna V TaubenbergerInstitute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia. TU Dresden, Biotechnology Center, Tatzberg, Dresden, Germany.
Christina TheodoropoulosInstitute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
Boris M HolzapfelInstitute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia. Orthopedic Center for Musculoskeletal Research, University of Wuerzburg, Brettreichstraße, Wuerzburg, Germany.
Olivier RamuzDepartment of Anatomical Pathology and Cytopathology, Pathology Queensland Central Laboratory, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Melanie StraubInstitute of Pathology, University Clinic Rechts der Isar, Technical University Munich, Trogerstr, Munich, Germany.
Dietmar W HutmacherInstitute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia. George W Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America. Institute for Advanced Study, Technical University Munich, Lichtenbergstraße, Garching, Germany.
Queensland University of Technology · AUInstitute for Advanced Study · DEKlinikum rechts der Isar · DERoyal Brisbane and Women's Hospital · AUTU Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone metastasis is a frequent and life-threatening complication of breast cancer. The molecular mechanisms supporting the establishment of breast cancer cells in the skeleton are still not fully understood, which may be attributed to the lack of suitable models that interrogate interactions between human breast cancer cells and the bone microenvironment. Although it is well-known that integrins mediate adhesion of malignant cells to bone extracellular matrix, their role during bone colonization remains unclear. Here, the role of β1 integrins in bone colonization was investigated using tissue-engineered humanized in vitro and in vivo bone models. In vitro, bone-metastatic breast cancer cells with suppressed integrin β1 expression showed reduced attachment, spreading, and migration within human bone matrix compared to control cells. Cell proliferation in vitro was not affected by β1 integrin knockdown, yet tumor growth in vivo within humanized bone microenvironments was significantly inhibited upon β1 integrin suppression, as revealed by quantitative in/ex vivo fluorescence imaging and histological analysis. Tumor cells invaded bone marrow spaces in the humanized bone and formed osteolytic lesions; osteoclastic bone resorption was, however, not reduced by β1 integrin knockdown. Taken together, we demonstrate that β1 integrins have a pivotal role in bone colonization using unique tissue-engineered humanized bone models.

Indexed as

AnimalsBone NeoplasmsBreast NeoplasmsCell Line, TumorDisease Models, AnimalFemaleHumansImmunohistochemistryIntegrin beta1MiceMice, Inbred NODMice, SCIDNeoplasm InvasivenessNeoplasm MetastasisTissue EngineeringIntegrin beta1

Identifiers

PMID25426561
PMCPMC4381598
OpenAlexW1601166589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.